Skip to main content
. 2011 May 17;11:174. doi: 10.1186/1471-2407-11-174

Table 2.

The associations between Ku70 polymorphisms and gastric cancer risk

Case (%) Control (%) Adjusted ORa (95% CI) P-value
promoter T-991C (rs5751129)
TT 106 (77.9) 502 (89.6) 1.00 (ref)
TC 26 (19.1) 52 (9.3) 2.41 (1.53-3.88) 0.0020
CC 4 (3.0) 6 (1.1) 3.21 (0.96-9.41) 0.0837
P for trend 2.87 (1.37-5.02) <0.0001
 (TC+CC) vs TT 2.48 (1.74-3.92) 0.0005
 CC vs (TT+TC) 2.67 (0.71-9.69) 0.1114
Promoter G-57C (rs2267437)
CC 95 (69.9) 383 (68.4) 1.00 (ref)
CG 37 (27.2) 167 (29.8) 0.91 (0.48-1.38) 0.6722
GG 4 (2.9) 10 (1.8) 1.56 (0.55-4.97) 0.4954
P for trend 0.93 (0.53-3.34) 0.6164
 (CG+GG) vs CC 0.98 (0.63-1.52) 0.8367
 GG vs (CC+CG) 1.52 (0.58-5.01) 0.4917
promoter A-31G (rs132770)
GG 109 (80.1) 459 (82.0) 1.00 (ref)
GA 19 (14.0) 73 (13.0) 1.16 (0.71-1.93) 0.7763
AA 8 (5.9) 28 (5.0) 1.25 (0.51-2.68) 0.6642
P for trend 1.18 (0.68-2.34) 0.9065
 (GA+AA) vs GG 1.14 (0.73-1.76) 0.6227
 AA vs (GG+GA) 1.03 (0.37-3.01) 0.6673
intron 3 (rs132774)
GG 113 (83.1) 459 (82.0) 1.00 (ref)
GC 23 (16.9) 101 (18.0) 0.91 (0.60-1.73) 0.8040
CC 0 (0.0) 0 (0.0)

a Adjusted by age and gender; the line with ORs that significantly differ from 1.00 are bolded